Medline, Inc. (MDLN)
36.24
-1.46
(-3.87%)
USD |
NASDAQ |
May 20, 16:00
36.38
+0.14
(+0.39%)
After-Hours: 20:00
Medline EPS Diluted (Quarterly) : 0.1525 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.6165 |
| Baxter International, Inc. | -0.0291 |
| Boston Scientific Corp. | 0.897 |
| Intuitive Surgical, Inc. | 2.283 |
| Stryker Corp. | 1.928 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 239.00M |
| Revenue (Quarterly) | 7.352B |
| Total Expenses (Quarterly) | 7.223B |
| Enterprise Value | 50.36B |
| Gross Profit Margin (Quarterly) | 22.65% |
| Profit Margin (Quarterly) | 3.25% |
| Earnings Yield | 3.30% |
| Operating Earnings Yield | 7.29% |
| Normalized Earnings Yield | 3.679 |